Literature DB >> 11301381

Hepatocellular carcinoma in the developing world.

J O Ogunbiyi1.   

Abstract

There has recently been an observable increase in some forms of cancer the world over. This is attributable in large part to the introduction of acquired immunodeficiency syndrome (AIDS)-related malignancies into the world of medicine and it is interesting that most of these cases are seen in the developing world, which proportionately leads with the number of AIDS cases. Despite this, some more traditional cancers remain the big killers in these areas of the world, except that in some countries definitive interventions have yielded excellent results in reducing disease burden. In Africa and the developing world, hepatocellular carcinoma (HCC) is the leading cause of cancer death, having some clearly established etiologic factors. This review describes the current status of each of these known etiologic factors in the various areas and, using available evidence, suggests options that may be employed to further stem the incidence of HCC and improve on survival in these populations. Semin Oncol 28:179-187. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Year:  2001        PMID: 11301381     DOI: 10.1016/s0093-7754(01)90090-9

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  7 in total

1.  Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.

Authors:  Kok Sun Looi; Ernesto S Nakayasu; Raquel A de Diaz; Eng M Tan; Igor C Almeida; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2008-08-02       Impact factor: 4.466

2.  Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.

Authors:  Muhammad Idrees; Shazia Rafique; Irshadur Rehman; Haji Akbar; Muhammad-Zubair Yousaf; Sadia Butt; Zunaira Awan; Sobia Manzoor; Madiha Akram; Mahwish Aftab; Bushra Khubaib; Sheikh Riazuddin
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

3.  Hepatocellular carcinoma in pakistan: where do we stand?

Authors:  Amna Subhan Butt; Zaigham Abbas; Wasim Jafri
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

4.  Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker.

Authors:  Zhaoyu Zhu; Zheng Liu; Yuchun Liu; Chunyan Wang; Ruyu Li; Hui Liu; Baohua Gu; Guodong Li; Shoutao Zhang
Journal:  FEBS Open Bio       Date:  2017-03-21       Impact factor: 2.693

5.  Sero-epidemiology of Hepatitis B Surface Antigenaemia among Adult Nigerians with Clinical Features of Liver Diseases Attending a Primary-Care Clinic in a Resource-Constrained Setting of Eastern Nigeria.

Authors:  Gabriel Uche Pascal Iloh; Austin Obiora Ikwudinma
Journal:  N Am J Med Sci       Date:  2013-04

6.  The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma.

Authors:  Asako Kimura; Kazuyuki Sogawa; Mamoru Satoh; Yoshio Kodera; Osamu Yokosuka; Takeshi Tomonaga; Fumio Nomura
Journal:  Int J Proteomics       Date:  2012-08-16

7.  MDM2 285G>C and 344T>A gene variants and their association with hepatocellular carcinoma: a Moroccan case-control study.

Authors:  Khadija Rebbani; Sayeh Ezzikouri; Agnès Marchio; Mostafa Kandil; Pascal Pineau; Soumaya Benjelloun
Journal:  Infect Agent Cancer       Date:  2014-04-07       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.